Entropix is an early-stage biotechnology company which specialises in the directed evolution of high-performance enzymes and biocatalysts.

The enzymes with improved performance are developed for a range of industries such as diagnostics, life sciences, manufacturing, pharmaceutical and food ingredient sectors.

They offer custom and/or proprietary enzyme development, enzyme bioprospecting and computational biology. Their computational enzyme development and experimental capabilities include:

• Gene sequencing, analysis, and design.
• High-yield, tunable mutagenesis.
• Protein expression, purification, and quantification.
• Fermentation.
• Enzyme screening techniques including diagnostics and chemical analysis.